title: Complete remission of advanced cutaneous leiomyosarcoma following isolated limb perfusion with high-dose tumour necrosis factor-alpha and melphalan.
authors.forename: A C
authors.initials: AC
authors.lastname: Häffner
authors.forename: K
authors.initials: K
authors.lastname: Zepter
authors.forename: T
authors.initials: T
authors.lastname: Fritz
authors.forename: R
authors.initials: R
authors.lastname: Dummer
authors.forename: F J
authors.initials: FJ
authors.lastname: Lejeune
authors.forename: G
authors.initials: G
authors.lastname: Burg
mesh_terms: D000368:Aged; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D010478:Chemotherapy, Cancer, Regional Perfusion; D005260:Female; D006801:Humans; D007866:Leg / Q000473:pathology; D007890:Leiomyosarcoma / Q000188:drug therapy* / Q000473:pathology; D008558:Melphalan / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D014409:Tumor Necrosis Factor-alpha; D008558:Melphalan